Access cutting-edge neuroblastoma treatment through this clinical trial at a research site in Honolulu. Study-provided care at no cost to qualified participants.
Access neuroblastoma specialists in Honolulu at no cost
This study follows strict safety protocols and ethical guidelines
All study-related neuroblastoma treatment provided free
Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study in combination with etoposide for subjects with relapsed/refractory neuroblastoma.
Sponsor: Giselle Sholler
Check if you qualify for this neuroblastoma clinical trial in Honolulu, HI
If you're searching for neuroblastoma treatment options in Honolulu, HI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Honolulu research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuroblastoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.